CRBU FY 2021 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$181M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M-22.4% YoY

Gross Profit

$9M89.7% margin

Operating Income

-$67M-697.8% margin

Net Income

-$67M-697.3% margin

EPS (Diluted)

$-1.11

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$36M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$442M

Total Liabilities

$55M

Stockholders' Equity

$388M

Cash & Equivalents

$240M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$12M	-22.4%
Gross Profit	$9M	-$22M	+139.0%
Operating Income	-$67M	-$36M	-85.4%
Net Income	-$67M	-$34M	-95.1%